抗菌药物输送系统的新方向:凝微球的制备和应用
Jiapeng Li1, Guotao Wei1, Yihao Yuan1
1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Science & Medicine, Northwest University, 229 North Taibai Road, Beilin District, Xi'an 710069, China.
Pharmaceutics
|April 26, 2025
概括
水凝微球 (HMS) 提供先进的抗微生物药物,克服了传统载体的局限性. 本综述探讨了HMS制备,特性和用于增强感染控制的应用.
科学领域:
- 生物材料科学 生物材料科学
- 药物运输 药物运输 药物运输
- 纳米技术纳米技术
背景情况:
- 传统的抗微生物载体面临着诸如药物负荷低,释放控制不良和细胞毒性等挑战.
- 水凝微球 (HMS) 正因其小尺寸,高负载能力和有针对性的交付潜力而成为有前途的载体.
研究的目的:
- 系统地审查水凝微球 (HMSs) 用于抗菌药物输送.
- 分析HMS制备方法,特性和治疗应用.
- 确定影响HMS性能和药物递送动态的关键参数.
主要方法:
- 对HMS准备策略的系统文献审查.
- 对HMS与药物输送相关的特征性质的分析.
- 在HMS中检查治疗应用和运输的抗微生物药物.
主要成果:
- HMS显示可调节的物理化学特性和生物相容性,可有效地运输抗微生物.
- 制备参数极大地影响HMS性能和药物释放动力学.
- HMS显示出深度向传递和改善感染控制的潜力.
结论:
- 水凝微球代表了抗微生物药物输送系统的重大进步.
- 优化制备参数对于提高HMS性能和临床转化至关重要.
- 需要进一步的研究和材料优化,以便在感染控制中广泛的临床应用.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...


